Published on in Vol 5, No 12 (2021): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19230, first published .
Creating a Digital Toolkit to Reduce Fatigue and Promote Quality of Life in Multiple Sclerosis: Participatory Design and Usability Study

Creating a Digital Toolkit to Reduce Fatigue and Promote Quality of Life in Multiple Sclerosis: Participatory Design and Usability Study

Creating a Digital Toolkit to Reduce Fatigue and Promote Quality of Life in Multiple Sclerosis: Participatory Design and Usability Study

Journals

  1. Howard Z, Win K, Guan V. Mobile apps used for people living with multiple sclerosis: A scoping review. Multiple Sclerosis and Related Disorders 2023;73:104628 View
  2. Gromisch E, Ehde D, Neto L, Haselkorn J, Agresta T, Gokhale S, Turner A. Using participatory action research to develop a new self-management program: Results from the design stage of Managing My MS My Way. Multiple Sclerosis and Related Disorders 2023;74:104720 View
  3. Üstündağ S, Yeşilbalkan Ö, Kabay S. The effect of a mobile education application (MobilMS) developed for multiple sclerosis patients in Turkey on symptom management and quality of life: A randomized controlled study. Multiple Sclerosis and Related Disorders 2024;81:105342 View
  4. Feng G, Posa S, Sureshkumar A, Simpson S, Bruno T, Morrow S, Donkers S, Knox K, Feinstein A, Bayley M, Munce S, Simpson R. Experiences of people with multiple sclerosis and clinicians in using cognitive behavioural therapies for hidden symptoms: a systematic review and meta-aggregation. Journal of Neurology 2024 View
  5. Fakolade A, Jackson A, Cardwell K, Finlayson M, O'Sullivan T, Tomasone J, Pilutti L. DigiTRAC: Qualitative insights from knowledge users to inform the development of a Digital Toolkit for enhancing resilience among multiple sclerosis caregivers. Multiple Sclerosis and Related Disorders 2024;88:105736 View
  6. Tea F, Groh A, Lacey C, Fakolade A. A scoping review assessing the usability of digital health technologies targeting people with multiple sclerosis. npj Digital Medicine 2024;7(1) View